The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The gap: Recognizing the inequities in oncology research and clinical practice guidelines—An analysis of clinical guidelines in multiple myeloma.
 
Samuel Ranger
Employment - IQVIA
 
Maya Birhiray
Consulting or Advisory Role - Regeneron (I); Sanofi (I); Seagen (I); Stemline Therapeutics (I); Takeda (I); TG Therapeutics (I)
Speakers' Bureau - Abbvie (I); Amgen (I); Array BioPharma (I); AstraZeneca (I); Blueprint Medicines (I); CTI (I); Daiichi Sankyo (I); E.R. Squibb Sons, LLC (I); Epizyme (I); Exelixis (I); Genzyme (I); GlaxoSmithKline (I); Incyte (I); Ipsen (I); Janssen Scientific Affairs (I); Johnson & Johnson (I); Lilly (I); MorphoSys (I); Pharmacyclics (I); Puma Biotechnology (I); SOBI (I)
 
Ruemu Birhiray
Consulting or Advisory Role - Regeneron; Sanofi; Seagan; Stemline Therapeutics; Takeda; TG Therapeutics
Speakers' Bureau - Abbvie; Amgen; Array BioPharma; AstraZeneca; Blueprint Medicines; CTI; Daiichi Sankyo; E.R. Squibb Sons, LLC; Epizyme; Exelixis; Genzada Pharmaceuticals; GlaxoSmithKline; Incyte; Ipsen; Janssen Scientific Affairs; Johnson & Johnson; Lilly; MorphoSys; Pharmacyclics; Puma Biotechnology; SOBI
 
Abbey Suess
No Relationships to Disclose